Clinical trials: Hypoactive Delirium
Anticholinergic Delirium, Clozapine Poisoning
Rivastigmine as an Antidote for Clozapine-induced Central Nervous System Depression and Delirium
This study aims to evaluate the clinical efficacy and safety of rivastigmine in reversing the full spectrum of anticholinergic delirium including hypoactive delirium which is presented with CNS depression and hyperactive or…
- Conditions
- Anticholinergic Delirium, Clozapine Poisoning, Antipsychotic Toxicity, CNS Depression
- Trial name
- NCT07545382
- Testing
- Rivastigmine
- Where
- Egypt
- Volunteers
- 100 people
- Sponsor
- Alexandria University
Hypoactive Delirium
The Basel BOMP-AID Randomized Trial
Delirium is a neurobehavioural syndrome that frequently develops in the postoperative and/or ICU setting. The incidence of elderly patients who develop delirium during hospital stay ranges from 11-82%.
- Trial name
- BOMP-AID (NCT03438526)
- Testing
- Melatonin (Circadin ®)
- Where
- Switzerland
- Volunteers
- 190 people
- Sponsor
- University Hospital, Basel, Switzerland
Hypoactive Delirium
A Comparison of Healthcare Provider and Caregiver Perception of Discomfort in Advanced Cancer Patients Who Have a Hypoactive Delirium
To learn about your feelings as a caregiver about the level of discomfort of patients who have hypoactive delirium (loss of contact and response to reality) and who are at the end of life
- Trial name
- NCT05837039
- Testing
- Healthcare Provider, Caregiver Perception
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- M.D. Anderson Cancer Center
Emergence Delirium, Hypoactive Delirium
An Observational Study of Emergence and Hypoactive Delirium After Anesthesia
Early postoperative negative behaviour (ePONB), such as pain, emergence delirium (ED) and hypoactive delirium, is a relevant clinical problem during recovery from anesthesia.
- Conditions
- Emergence Delirium, Hypoactive Delirium, Pain
- Trial name
- NCT05582005
- Testing
- noninvasive blood pressure, 3 lead ECG, peripheral oxygen saturation
- Where
- Canada
- Volunteers
- 150 people
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
Hypoactive Delirium
Flumazenil for Hypoactive Delirium Secondary to Benzodiazepine Exposure
Delirium within the intensive care unit (ICU) is associated with poor outcomes such as increased mortality, ICU and hospital length of stay (LOS), and time on mechanical ventilation.
- Trial name
- FLYP (NCT02899156)
- Testing
- Flumazenil
- Where
- United States
- Volunteers
- 22 people
- Sponsor
- University of California, Davis
Hyperactive Delirium, Hypoactive Delirium
A Pilot Study of "Stanford Proxy Test for Delirium" (S-PTD)
Although there are several tools available for the screening of delirium among the medically ill, they all have some limitations.
- Conditions
- Hyperactive Delirium, Hypoactive Delirium, Mixed Type Delirium
- Trial name
- NCT03954769
- Where
- United States
- Volunteers
- 300 people
- Sponsor
- Stanford University
Hypoactive Delirium, Hyperactive Delirium
Delirium Prevention in Patients From the Intensive Care Unit (DELA)
"To determine the efficacy of program of prevention of delirium in critically ill patients from the intensive care units of Bucaramanga and Floridablanca.
- Conditions
- Hypoactive Delirium, Hyperactive Delirium, Delirium of Mixed Origin
- Trial name
- DELA (NCT03215745)
- Testing
- Delirium prevention program
- Where
- Colombia
- Volunteers
- 200 people
- Sponsor
- Universidad de Santander
Hypoactive Delirium
Treatment of Hypoactive Delirium and Outcome Measures
Haloperidol and Non-Pharmacologic Treatment are recognized treatments for delirium. This study will evaluate which is the best treatment for hypoactive delirium.
- Trial name
- THDOM (NCT02345902)
- Testing
- Haloperidol, non-pharmacologic measures
- Where
- Mexico
- Volunteers
- 60 people
- Sponsor
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran